Yuhan to become largest shareholder in Theragen Etex

Theragen Etex, a Korean research and development company looking at biologics and small molecules, said Monday that Yuhan Corp. will become the largest shareholder as it holds a 9.18 percent stake.

Last August, Theragen and Yuhan signed an agreement to commercialize Theragen’s "Hellogenom," which codes 1 million genome pairs per person. If a person sends a saliva sample in a kit, they will b...